@ARTICLE{
author={Sacca Francesco,Gialdini Gino,Howard James F,Vu Tuan H,Meisel Andreas,Peric Stojan Z,Lunemann Jan D,Sgarzi Manlio,Shaibani Aziz,Bril Vera,Yeh Jiann-Horng,Reyes-Garrido Virginia,Liao Serena,Metais Camille,Van der Valk Ralf JP},
year={2026},
title={Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis},
journal={JAMA NEUROLOGY},
volume={},
number={},
pages={-},
document_type={Article; Early Access},
} 

@ARTICLE{
author={Hoffmann S,Meisel Andreas,Attarian S,De Bleecker J,Vissing J,Kerstens R,Brauer E,Utsugisawa Kimiaki,Goyal N,Li Y,Peric Stojan Z,Howard J,Sacca Francesco},
year={2023},
title={Efgartigimod Demonstrates Consistent Magnitude of Response Across Subgroups of Patients With gMG},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={30},
number={},
pages={357-358},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Sacca Francesco,Barnett Carolina,Vu Tuan,Peric Stojan Z,Phillips Glenn A,Zhao Sihui,Qi Cynthia Z,Gelinas Deborah,Chiroli Silvia,Verschuuren Jan JGM},
year={2023},
title={Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)},
journal={JOURNAL OF NEUROLOGY},
volume={270},
number={4},
pages={2096-2105},
document_type={Article},
} 

@ARTICLE{
author={Sacca Francesco,Barnett-Tapia C,Vu T,Peric Stojan Z,Phillips Glenn A,Zhao Sihui,Gelinas D,Chiroli Silvia,Verschuuren J},
year={2022},
title={Efgartigimod improved quality-of-life in gMG: a randomised, double-blinded, placebo-controlled, phase 3 trial (ADAPT)},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={29},
number={},
pages={240-240},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James F Jr,Bril Vera,Tuan Vu,Karam Chafic,Peric Stojan Z,De Bleecker Jan L,Murai Hiroyuki,Pasnoor Mamatha,Sacca Francesco,Meisel Andreas,Guglietta Antonio,T'joen Caroline,Utsugisawa Kimiaki,Verschuuren Jan,Mantegazza Renato},
year={2022},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies},
journal={MUSCLE & NERVE},
volume={65},
number={},
pages={S13-S14},
document_type={Meeting Abstract},
}